Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers

Takao Takahashi, Hiroyuki Konishi, Ken Ichi Kozaki, Hirotaka Osada, Shigetoyo Saji, Toshitada Takahashi, Takashi Takahashi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The chromosome region 17p13 is known to be frequently deleted in lung cancers. We recently showed the presence of an independent, commonly deleted region at 17p13.3, suggesting that in addition to p53 at 17p13.1 an as-yet-unidentified tumor suppressor gene may reside in this telomeric region, interestingly, the chromosomal location of a recently isolated novel myc antagonist gene, termed ROX/Mnt, coincides exactly with the centromeric border of the commonly deleted region at 17p13.3 in lung cancers. In conjunction with the generally acknowledged roles of myc genes in the pathogenesis of lung cancers, these findings led us to investigate whether ROX/Mnt is altered in lung cancers. Despite an extensive search for alterations in 52 lung cancer specimens, somatic mutations of ROX/Mnt could not be identified. We conclude that ROX/Mnt itself is not a frequent target for 17p13.3 deletions in lung cancers and that further explorations are required to identify the putative tumor suppressor gene at 17p13.3.

Original languageEnglish
Pages (from-to)347-351
Number of pages5
JournalJapanese Journal of Cancer Research
Volume89
Issue number4
Publication statusPublished - Apr 1998
Externally publishedYes

Fingerprint

Lung Neoplasms
myc Genes
Tumor Suppressor Genes
Chromosomes
Mutation

Keywords

  • 17p13.3
  • Lung cancer
  • Mnt
  • ROX

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Takahashi, T., Konishi, H., Kozaki, K. I., Osada, H., Saji, S., Takahashi, T., & Takahashi, T. (1998). Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers. Japanese Journal of Cancer Research, 89(4), 347-351.

Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers. / Takahashi, Takao; Konishi, Hiroyuki; Kozaki, Ken Ichi; Osada, Hirotaka; Saji, Shigetoyo; Takahashi, Toshitada; Takahashi, Takashi.

In: Japanese Journal of Cancer Research, Vol. 89, No. 4, 04.1998, p. 347-351.

Research output: Contribution to journalArticle

Takahashi, T, Konishi, H, Kozaki, KI, Osada, H, Saji, S, Takahashi, T & Takahashi, T 1998, 'Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers', Japanese Journal of Cancer Research, vol. 89, no. 4, pp. 347-351.
Takahashi T, Konishi H, Kozaki KI, Osada H, Saji S, Takahashi T et al. Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers. Japanese Journal of Cancer Research. 1998 Apr;89(4):347-351.
Takahashi, Takao ; Konishi, Hiroyuki ; Kozaki, Ken Ichi ; Osada, Hirotaka ; Saji, Shigetoyo ; Takahashi, Toshitada ; Takahashi, Takashi. / Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers. In: Japanese Journal of Cancer Research. 1998 ; Vol. 89, No. 4. pp. 347-351.
@article{cc47d39a78ef4e5496464b0993c320a0,
title = "Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers",
abstract = "The chromosome region 17p13 is known to be frequently deleted in lung cancers. We recently showed the presence of an independent, commonly deleted region at 17p13.3, suggesting that in addition to p53 at 17p13.1 an as-yet-unidentified tumor suppressor gene may reside in this telomeric region, interestingly, the chromosomal location of a recently isolated novel myc antagonist gene, termed ROX/Mnt, coincides exactly with the centromeric border of the commonly deleted region at 17p13.3 in lung cancers. In conjunction with the generally acknowledged roles of myc genes in the pathogenesis of lung cancers, these findings led us to investigate whether ROX/Mnt is altered in lung cancers. Despite an extensive search for alterations in 52 lung cancer specimens, somatic mutations of ROX/Mnt could not be identified. We conclude that ROX/Mnt itself is not a frequent target for 17p13.3 deletions in lung cancers and that further explorations are required to identify the putative tumor suppressor gene at 17p13.3.",
keywords = "17p13.3, Lung cancer, Mnt, ROX",
author = "Takao Takahashi and Hiroyuki Konishi and Kozaki, {Ken Ichi} and Hirotaka Osada and Shigetoyo Saji and Toshitada Takahashi and Takashi Takahashi",
year = "1998",
month = "4",
language = "English",
volume = "89",
pages = "347--351",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers

AU - Takahashi, Takao

AU - Konishi, Hiroyuki

AU - Kozaki, Ken Ichi

AU - Osada, Hirotaka

AU - Saji, Shigetoyo

AU - Takahashi, Toshitada

AU - Takahashi, Takashi

PY - 1998/4

Y1 - 1998/4

N2 - The chromosome region 17p13 is known to be frequently deleted in lung cancers. We recently showed the presence of an independent, commonly deleted region at 17p13.3, suggesting that in addition to p53 at 17p13.1 an as-yet-unidentified tumor suppressor gene may reside in this telomeric region, interestingly, the chromosomal location of a recently isolated novel myc antagonist gene, termed ROX/Mnt, coincides exactly with the centromeric border of the commonly deleted region at 17p13.3 in lung cancers. In conjunction with the generally acknowledged roles of myc genes in the pathogenesis of lung cancers, these findings led us to investigate whether ROX/Mnt is altered in lung cancers. Despite an extensive search for alterations in 52 lung cancer specimens, somatic mutations of ROX/Mnt could not be identified. We conclude that ROX/Mnt itself is not a frequent target for 17p13.3 deletions in lung cancers and that further explorations are required to identify the putative tumor suppressor gene at 17p13.3.

AB - The chromosome region 17p13 is known to be frequently deleted in lung cancers. We recently showed the presence of an independent, commonly deleted region at 17p13.3, suggesting that in addition to p53 at 17p13.1 an as-yet-unidentified tumor suppressor gene may reside in this telomeric region, interestingly, the chromosomal location of a recently isolated novel myc antagonist gene, termed ROX/Mnt, coincides exactly with the centromeric border of the commonly deleted region at 17p13.3 in lung cancers. In conjunction with the generally acknowledged roles of myc genes in the pathogenesis of lung cancers, these findings led us to investigate whether ROX/Mnt is altered in lung cancers. Despite an extensive search for alterations in 52 lung cancer specimens, somatic mutations of ROX/Mnt could not be identified. We conclude that ROX/Mnt itself is not a frequent target for 17p13.3 deletions in lung cancers and that further explorations are required to identify the putative tumor suppressor gene at 17p13.3.

KW - 17p13.3

KW - Lung cancer

KW - Mnt

KW - ROX

UR - http://www.scopus.com/inward/record.url?scp=0031959321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031959321&partnerID=8YFLogxK

M3 - Article

C2 - 9617337

AN - SCOPUS:0031959321

VL - 89

SP - 347

EP - 351

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 4

ER -